PropertyValue
?:abstract
  • The need for timely establishment of diagnostic assays of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is demanded in laboratories worldwide We evaluated the performance of a flow immunoassay which can detect IgM an IgG antibodies simultaneously against SARS-CoV-2 virus in human blood within 15 min Among the 132 positive novel Coronavirus Disease 19 (COVID-19) cases, 126 tests were consistent with previous quantitative Real Time PCR (qRT-PCR) assays Among the 62 negative cases, 60 were consistent with qRT-PCR assays except for 2 cases In this study, 2019-nCOV/COVID-19 IgG/IgM Rapid Test Device showed 95 5% sensitivity and 96 8% specificity In conclusion, Rapid IgM-IgG Combined Antibody Test showed high detection consistency among all analysed samples Suggesting that could be used for the rapid screening of SARS-CoV-2 carriers, either symptomatic or asymptomatic
is ?:annotates of
?:creator
?:journal
  • American_Journal_of_Infectious_Diseases
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Evaluation of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection: Single Italian Center Study
?:type
?:who_covidence_id
  • #805469
?:year
  • 2020

Metadata

Anon_0  
expand all